Hulstein JJ - Search Results

1

beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation.

Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot PG. Hulstein JJ, et al. Blood. 2007 Sep 1;110(5):1483-91. doi: 10.1182/blood-2006-10-053199. Epub 2007 May 8. Blood. 2007. PMID: 17488878 Free article. Clinical Trial.

2

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.

Hulstein JJ, de Groot PG, Silence K, Veyradier A, Fijnheer R, Lenting PJ. Hulstein JJ, et al. Blood. 2005 Nov 1;106(9):3035-42. doi: 10.1182/blood-2005-03-1153. Epub 2005 Jul 12. Blood. 2005. PMID: 16014562 Free article.

3

Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation.

van der Vorm LN, Li L, Huskens D, Hulstein JJJ, Roest M, de Groot PG, Ten Cate H, de Laat B, Remijn JA, Simons SO. van der Vorm LN, et al. Among authors: hulstein jjj. Respir Med. 2020 Sep;171:106094. doi: 10.1016/j.rmed.2020.106094. Epub 2020 Jul 25. Respir Med. 2020. PMID: 32758992 Free article.

4

The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.

Luken BM, Turenhout EA, Hulstein JJ, Van Mourik JA, Fijnheer R, Voorberg J. Luken BM, et al. Among authors: hulstein jj. Thromb Haemost. 2005 Feb;93(2):267-74. doi: 10.1160/TH04-05-0301. Thromb Haemost. 2005. PMID: 15711742

5

Sweat analysis using indirect ion-selective electrode on the routine chemistry analyser meets UK guidelines.

Hulstein JJ, van 't Sant P. Hulstein JJ, et al. Ann Clin Biochem. 2011 Jul;48(Pt 4):374-6. doi: 10.1258/acb.2011.011001. Epub 2011 Jun 7. Ann Clin Biochem. 2011. PMID: 21652687

6

A retrospective Cohort study on the effect of the LOw-molecular weighT heparin (LMWH) nadroparin dose on anti-XA levels in a mixed medical-surgical ICU population: CLOT-Xa.

van Berkel L, Kuindersma M, van Iperen ID, Adriaansen HJ, Hulstein JJJ, Spronk PE. van Berkel L, et al. Among authors: hulstein jjj. J Crit Care. 2024 Dec 16;86:154991. doi: 10.1016/j.jcrc.2024.154991. Online ahead of print. J Crit Care. 2024. PMID: 39689379

7

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.

Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, de Groot PG, Fijnheer R. Hulstein JJ, et al. J Thromb Haemost. 2006 Dec;4(12):2569-75. doi: 10.1111/j.1538-7836.2006.02205.x. Epub 2006 Sep 12. J Thromb Haemost. 2006. PMID: 16968329 Free article.

8

FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura.

Groot E, Hulstein JJ, Rison CN, de Groot PG, Fijnheer R. Groot E, et al. Among authors: hulstein jj. J Thromb Haemost. 2006 Mar;4(3):698-9. doi: 10.1111/j.1538-7836.2005.01767.x. J Thromb Haemost. 2006. PMID: 16460463 Free article. No abstract available.

9

[Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].

Hulstein JJ, Rison CN, Kappers-Klunne MC, Hene RJ, Franx A, de Groot PG, Brand A, Fijnheer R. Hulstein JJ, et al. Ned Tijdschr Geneeskd. 2004 Oct 2;148(40):1972-6. Ned Tijdschr Geneeskd. 2004. PMID: 15524133 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters